statistiche ricercatore

Continente	#
NA - Nord America	797
AS - Asia	347
EU - Europa	301
SA - Sud America	60
Continente sconosciuto - Info sul continente non disponibili	31
AF - Africa	10
OC - Oceania	7
Totale	1.553

Nazione	#
US - Stati Uniti d'America	782
SG - Singapore	142
VN - Vietnam	76
CN - Cina	67
IT - Italia	64
RU - Federazione Russa	64
BR - Brasile	44
GB - Regno Unito	28
DE - Germania	23
FI - Finlandia	19
FR - Francia	17
SE - Svezia	17
CA - Canada	10
KR - Corea	10
LV - Lettonia	10
ID - Indonesia	9
IN - India	9
AT - Austria	8
ES - Italia	8
AU - Australia	7
NL - Olanda	7
PL - Polonia	7
CZ - Repubblica Ceca	6
ZA - Sudafrica	6
AR - Argentina	5
BD - Bangladesh	5
CH - Svizzera	5
BG - Bulgaria	4
EC - Ecuador	4
HK - Hong Kong	4
IL - Israele	4
IQ - Iraq	4
MX - Messico	4
PH - Filippine	3
UA - Ucraina	3
BE - Belgio	2
CL - Cile	2
CO - Colombia	2
IR - Iran	2
JP - Giappone	2
KE - Kenya	2
KZ - Kazakistan	2
LT - Lituania	2
AE - Emirati Arabi Uniti	1
BO - Bolivia	1
DK - Danimarca	1
DZ - Algeria	1
GR - Grecia	1
HN - Honduras	1
IE - Irlanda	1
JO - Giordania	1
KG - Kirghizistan	1
MA - Marocco	1
MD - Moldavia	1
OM - Oman	1
PE - Perù	1
PK - Pakistan	1
PY - Paraguay	1
RO - Romania	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TR - Turchia	1
UZ - Uzbekistan	1
Totale	1.522

Nome	#
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface	234
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models	234
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine	196
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform	166
Characterisation of detergent-insoluble membranes in pollen tubes of Nicotiana tabacum (L.)	149
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines	127
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells	123
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine	109
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles	101
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells	87
Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain	27
Totale	1.553

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	83	0	6	2	7	8	3	2	14	9	8	10	14
2022/2023	95	11	11	6	17	5	12	2	8	9	1	5	8
2023/2024	73	1	3	5	2	2	21	7	5	0	6	3	18
2024/2025	295	7	0	30	61	12	28	3	17	13	66	21	37
2025/2026	699	60	22	77	125	67	49	115	15	72	54	25	18
2026/2027	31	8	23	0	0	0	0	0	0	0	0	0	0
Totale													1.553